amjtransplant.org
A Phase 2 Multi-Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell a...
Norovirus (NoV) may cause or contribute to chronic diarrhea among immunocompromised
hosts. Neither vaccines nor antiviral therapies are available to prevent or treat
NoV. We conducted an NIH-sponsored...